Goldman Sachs’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Goldman Sachs’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-541,009	Closed	-$19.4M	–	6499
2022 Q4	$19.4M	Buy	541,009 +515,384	+2,011%	+$12.9M	﹤0.01%	1990
2022 Q3	$385K	Sell	25,625 -195,057	-88%	-$3.16M	﹤0.01%	5147
2022 Q2	$2.96M	Buy	220,682 +125,855	+133%	+$2M	﹤0.01%	3692
2022 Q1	$1.83M	Buy	94,827 +7,065	+8%	+$147K	﹤0.01%	4336
2021 Q4	$2.08M	Buy	+87,762	New	+$2.03M	﹤0.01%	4209

Goldman Sachs's IMGO Position: Q1 2023 in Review

Goldman Sachs sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 541,009 shares — an estimated $19.4M sold.

Goldman Sachs first reported a position in IMGO in Q4 2021 and held it in 5 quarters. The position peaked at $19.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Goldman Sachs reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Goldman Sachs sold 541,009 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $19.4M.
Goldman Sachs first reported a position in Imago BioSciences, Inc. Common stock in Q4 2021 and held it in 5 quarters.
Goldman Sachs's Imago BioSciences, Inc. Common stock position peaked at $19.4M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.